Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies

被引:82
作者
Harel, Zeev [1 ]
机构
[1] Brown Univ, Hasbro Childrens Hosp, Rhode Isl Hosp,Dept Pediat, Warren Alpert Med Sch,Div Adolescent Med, Providence, RI 02912 USA
关键词
adolescents; dysmenorrhea; endometriosis; young adults; CHRONIC PELVIC PAIN; ADD-BACK THERAPY; DOUBLE-BLIND; MEDROXYPROGESTERONE ACETATE; INTRAUTERINE SYSTEM; ORAL-CONTRACEPTIVES; MENSTRUAL PAIN; SYMPTOMATIC ENDOMETRIOSIS; AROMATASE INHIBITORS; CONTROLLED-TRIAL;
D O I
10.1517/14656566.2012.725045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Dysmenorrhea is the most common gynecologic complaint among adolescents/young adults. Dysmenorrhea is usually primary and is associated with normal ovulatory cycles and with no pelvic pathology. Potent prostaglandins and potent leukotrienes play an important role in generating primary dysmenorrhea symptoms. Adolescents/young adults with severe dysmenorrhea symptoms may have pelvic abnormalities, such as endometriosis or uterine anomalies (secondary dysmenorrhea). Areas covered: This review provides an update on treatments and management strategies of dysmenorrhea in adolescents/young adults. Medical literature articles were retrieved using a Medline search on primary and secondary dysmenorrhea. Original articles from peer-reviewed journals were selected based on relevance. Expert opinion: Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) is the preferred initial treatment for dysmenorrhea in nonsexually active adolescents/young adults. Adolescents/young adults with symptoms that do not respond to NSAIDs for three menstrual periods should be offered hormonal treatment, such as combined estrogen and progestin oral contraceptive pills (OCPs), for three menstrual cycles. If dysmenorrhea does not improve within 6 months of NSAIDs and OCPs, a laparoscopy is indicated to look for endometriosis, which is the most common reason for secondary dysmenorrhea.
引用
收藏
页码:2157 / 2170
页数:14
相关论文
共 108 条
  • [1] Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial
    Abbott, J
    Hawe, J
    Hunter, D
    Holmes, M
    Finn, P
    Garry, R
    [J]. FERTILITY AND STERILITY, 2004, 82 (04) : 878 - 884
  • [2] ACOG Committee on Practice Bulletins--Gynecology, 2004, Obstet Gynecol, V103, P589
  • [3] Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study
    Ailawadi, RK
    Jobanputra, S
    Kataria, M
    Gurates, B
    Bulun, SE
    [J]. FERTILITY AND STERILITY, 2004, 81 (02) : 290 - 296
  • [4] Continuous low-level topical heat in the treatment of dysmenorrhea
    Akin, MD
    Weingand, KW
    Hengehold, DA
    Goodale, MB
    Hinkle, RT
    Smith, RP
    [J]. OBSTETRICS AND GYNECOLOGY, 2001, 97 (03) : 343 - 349
  • [5] ALLEN C, 2005, COCHRANE DB SYST REV, V4
  • [6] ALVIN PE, 1982, PEDIATRICS, V70, P516
  • [7] American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V105, P921
  • [8] Anastrazole and oral contraceptives: a novel treatment for endometriosis
    Amsterdam, LL
    Gentry, W
    Jobanputra, S
    Wolf, M
    Rubin, SD
    Bulun, SE
    [J]. FERTILITY AND STERILITY, 2005, 84 (02) : 300 - 304
  • [9] [Anonymous], 2010, Obstet Gynecol, V115, P206, DOI 10.1097/AOG.0b013e3181cb50b5
  • [10] Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives
    Archer, David F.
    [J]. CONTRACEPTION, 2006, 74 (05) : 359 - 366